IRVINE, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (NASDAQ:OCX), a pioneering diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will attend BTIG's MedTech, Digital Health, Life Science & Diagnostic Tools Conference in Snowbird, Utah. Oncocyte will host one-on-one meetings with interested investors.Investors attending the conference wishing to schedule a meeting are encouraged to contact BTIG to schedule.Event: BTIG's MedTech, Digital Health, Life Science & ...Full story available on Benzinga.com
Oncocyte is a California-based precision diagnostics company that develops and commercializes blood-based molecular diagnostic tests for the treatment of lung cancer.